Scouting report · BLLN

Ross Taylor

CFO since January 2024; previously CFO of Codexis and Abaxis

Born / age
(62)
Role
Chief Financial Officer (principal financial and accounting officer)
In the role
3 yr
Education
MBA Columbia Business School
Front Office rank
not ranked yet
BLLN
BillionToOne, Inc.Diagnostics
Title
Chief Financial Officer (principal financial and accounting officer)src
In role
since 2024-01 (3 yr)
Stake value—no holding or price on file
—thin record

Scouting sheetas of 24 Sep 2026

Delivers guidance—no promises on the record yet
Answers the question—no call reviewed yet
Capital allocation—company not reviewed yet
Pay design—no proxy read yet
Skin in the game—no holding or price on file
—Hit rate
—Pay at risk
—Say-on-pay
—Airtime on calls
Beat
0
Met
0
Missed
0
Withdrawn
0
Still open
0
Answers on calls
0
Questions dodged
0
Dodges / 100 answers
—

Personal and ownership data

Full name
Ross Taylor
Age
62src
Education
MBA, Columbia Business Schoolsrc

Not on file yet: born, place of birth, citizenship, marital status.

Shares held
80,208 BLLN, 2025-09-30src
Traded, 12 months
bought $0, sold $0src
Last pay
$2.1m 2024src

What to weigh

Watch 3

  • His pay after 2024 is undisclosed. He was a named executive in the IPO prospectus (2024) but not in the 2026 proxy, which as an emerging growth company covers only three officers. The prospectus set his post-IPO salary at $500,000 with a 50% bonus targetsrc
  • Two tenures ended within a few years: Abaxis on its sale (about three years as CFO) and Codexis after about 3.5 years, with a severance agreementsrc
  • Skin in the game is options only. At the IPO he held no common stock, just 175,000 options at $11.55 and 75,000 at $30.78, both time-vestedsrc

In their favour 1

  • He has filed no Form 4 transaction since the IPO and no Form 144 notice of a sale. Most officers, the CEO included, have been selling since June 2026src

Pay

Salary and otherBonus, stock, options, incentive

  • $2.1m2024
The table
YearSalaryBonusStockOptionsIncentiveOtherTotal
2024$297k$149k$0$1.6m$0$5k$2.1msrc

Career

  1. 2024-01 – now
    BillionToOne, Inc.src
    Chief Financial Officer
    Hire announced 2024-02-21 (WS-blln-2024); CFO through the November 2025 IPO
  2. 2019-08 – 2023-01
    Codexis, Inc.src
    Senior Vice President & Chief Financial Officer
    Effective 2019-08-19, succeeding the retiring Gordon Sangster. Ceased to be CFO 2023-01-23 and stayed as an adviser until 2023-03-06 (CDXS-8K-2023-02-03)
  3. 2015-08 – 2018-07
    Abaxis, Inc.src
    Chief Financial Officer
    CFO through the sale of Abaxis to Zoetis for $2.0bn in July 2018
  4. 2014-10 – 2015-07
    Abaxis, Inc.src
    Vice President of Business Development & Investor Relations
  5. 2005 – 2014
    CL King & Associatessrc
    Healthcare equity research analyst (healthcare equipment and supplies)
  6. 1999 – 2001
    UBSsrc
    Equity research analyst, biotechnology
  7. 1996 – 1999
    Smith Barneysrc
    Equity research analyst, healthcare services
    The proxy also lists CJ Lawrence among his research employers, undated

Not located: 2018-08 to 2019-08 (between the Abaxis sale and Codexis) and 2023-03 to 2024-01 (between Codexis and BillionToOne) not described in any source searched; 2001-2005 not located

The promise ledger

No promise on the record yet: the research routine has not scored this company's guidance.

Background

  • Family The 2026 proxy states there are no family relationships among any nominees, directors or executive officerssrc
  • Other Left the Codexis CFO post on 2023-01-23 when a new CFO was appointed. Under a transition and separation agreement he advised the CEO until 2023-03-06 and received 12 months' base salary as severance plus 85% of his 2022 target bonus. His unvested Codexis equity was forfeitedsrc
  • Other A Tier 2 participant in the executive severance plan: 9 months' salary on an involuntary termination, or 100% of salary plus target bonus and full equity vesting on one within 12 months of a change in controlsrc

Sources8